Amber Hill, PhD, is a distinguished figure in the intersection of research, global community engagement, and AI technology. She is the founder and CEO of Research Grid (R.grid), a pioneering AI tech company that has developed an automation engine for admin-free clinical trials. Dr. Hill holds a PhD in Biomedical Neuroscience from University College London (UCL), where she also completed a postdoctoral fellowship focusing on widening access to research through AI, supplemented by a stint in Computer Science at Harvard University. Additionally, she has enhanced her leadership skills through a management program at MIT Sloan.
During her time as a student, Dr. Hill founded the nonprofit Movement for Hope, which engages in cross-disciplinary initiatives globally to raise awareness for neurological conditions and broaden access to research. At Research Grid, Dr. Hill leads the development of two innovation products -Inclusive and TrialEngine – which automates back-office tasks for engagement and clinical trials, respectively, streamlining processes to enhance efficiency and accessibility in medical research.